[Standards] Educational Achievement comments and recommendations
mstanton at pernixtx.com
Mon Oct 3 20:40:08 UTC 2016
Thank you Valerie - no changes from me. Marsha
Marsha Stanton, PhD, RN
Pernix Therapeutics, Inc
Exec. Director, Medical Affairs, Program Development/Education
4400 Sunfield Ave
Long Beach, CA 90808
mstanton at pernixtx.com<mailto:mstanton at pernixtx.com>
From: Standards [mailto:standards-bounces at medbiq.org] On Behalf Of Valerie Smothers
Sent: Friday, September 30, 2016 4:57 AM
To: standards at medbiq.org
Subject: [Standards] Educational Achievement comments and recommendations
Dear Standards Committee,
The Educational Trajectory Working Group reviewed the compiled comments from the Standards Committee and has provided recommendations and proposed edits in response. There are two attached documents: one that shows compiled suggestions and recommendations and the revised spec. Please review and provide any comments by next Friday. October 7. Thank you!
Note that the proposed changes reflect feedback on the Educational Achievement spec from the ABP and NBME. The previous specification did not allow for the exchange of information related to the role of an observer making an assessment (ie attending physician, nurse, peer, etc) or the duration of the observation period for the assessment (one day, 30 days, etc). We've incorporated that feedback into the proposed changes, which are attached to this note. Adding these fields would make integration across systems involved in observational assessment more robust.
vsmothers at jhmi.edu<mailto:vsmothers at jhmi.edu>
Sign up for our newsletter!<http://visitor.constantcontact.com/manage/optin/ea?v=001MV7eEgn-X0pc_X-SYPDDLA%3D%3D>
Follow us on Twitter<https://twitter.com/medbiq>
This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed. This message contains confidential information and is intended only for the individual named. If you are not the named addressee you should not disseminate, distribute or copy this e-mail. Please notify the sender immediately by e-mail if you have received this e-mail by mistake and delete this e-mail from your system. If you are not the intended recipient you are notified that disclosing, copying, distributing or taking any action in reliance on the contents of this information is strictly prohibited. - Pernix Therapeutics Holdings, Inc
-------------- next part --------------
An HTML attachment was scrubbed...
More information about the Standards